Your browser doesn't support javascript.
loading
Guideline Development for Medical Device Technology: Issues for Consideration.
Battelino, Tadej; Brosius, Frank; Ceriello, Antonio; Cosentino, Francesco; Green, Jennifer; Kellerer, Monika; Koob, Susan; Kosiborod, Mikhail; Lalic, Nebojsa; Marx, Nikolaus; Nedungadi, T Prashant; Rydén, Lars; Rodbard, Helena W; Ji, Linong; Sheu, Wayne Huey-Herng; Standl, Eberhard; Parkin, Christopher G; Schnell, Oliver.
Afiliación
  • Battelino T; University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia.
  • Brosius F; University of Arizona College of Medicine-Tucson, AZ, USA.
  • Ceriello A; IRCCS MultiMedica, Milan, Italy.
  • Cosentino F; Cardiology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Green J; Duke University Medical Center, Duke Clinical Research Institute, Durham, NC, USA.
  • Kellerer M; Marienhospital Stuttgart, Stuttgart, Germany.
  • Koob S; PCNA National Office, Madison, WI, USA.
  • Kosiborod M; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Lalic N; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
  • Marx N; Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia.
  • Nedungadi TP; Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.
  • Rydén L; American Heart Association, Dallas, TX, USA.
  • Rodbard HW; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden.
  • Ji L; Endocrine and Metabolic Consultants, Rockville, MD, USA.
  • Sheu WH; Peking University People's Hospital, Beijing, China.
  • Standl E; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung City.
  • Parkin CG; Forschergruppe Diabetes e.V., Munich, Germany.
  • Schnell O; CGParkin Communications Inc., Henderson, NV, USA.
J Diabetes Sci Technol ; 17(6): 1698-1710, 2023 11.
Article en En | MEDLINE | ID: mdl-35531901
ABSTRACT
Advances in the development of innovative medical devices and telehealth technologies create the potential to improve the quality and efficiency of diabetes care through collecting, aggregating, and interpreting relevant health data in ways that facilitate more informed decisions among all stakeholder groups. Although many medical societies publish guidelines for utilizing these technologies in clinical practice, we believe that the methodologies used for the selection and grading of the evidence should be revised. In this article, we discuss the strengths and limitations of the various types of research commonly used for evidence selection and grading and present recommendations for modifying the process to more effectively address the rapid pace of device and technology innovation and new product development.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Telemedicina / Diabetes Mellitus Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Diabetes Sci Technol Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Eslovenia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Telemedicina / Diabetes Mellitus Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Diabetes Sci Technol Asunto de la revista: ENDOCRINOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Eslovenia